[{"ID":"12720_27_NCT03296930","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nNo, the patient is excluded from the clinical trial because of the presence of chronic HCV infection, which is an inclusion criterion for the trial. Additionally, the patient's recent biopsy was negative for hepatocellular carcinoma, which is a exclusion criterion for the trial.\n\n{%E2%80%8B%20excluded%20\n\nThe patient is not relevant for the clinical trial because the trial is focused on the effect of direct acting antiviral drugs on normal kidney function, and the patient's medical history and current condition do not meet the inclusion criteria for the trial.\n\n{%E2%80%8B%20not%20relevant%20\n\nPlease select one of the options in the bracket.","PROBA":0.9828653577},{"ID":"30672_65_NCT01883024","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nThe patient is eligible for the clinical trial because they meet the inclusion criteria of having type 1 diabetes and using insulin pump therapy, and they do not have any of the exclusion criteria such as pregnancy, breastfeeding, current infectious disease, lack of smartphone or internet access, or legal protection.","PROBA":0.9955299842},{"ID":"12418_27_NCT00720434","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. excluded","PROBA":0.878233932},{"ID":"17032_36_NCT01491828","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nThe patient is eligible for the clinical trial because she does not have any of the exclusion criteria listed in the clinical trial. She does not have a known hypersensitivity or hyposensitivity to vibrations on the neck, no neurological disorder, no psychiatric disorder, and she is not pregnant. Therefore, she meets all the inclusion criteria and none of the exclusion criteria, making her eligible for the clinical trial.","PROBA":0.9939137518},{"ID":"7100_15_NCT04821219","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.9886336699},{"ID":"8090_17_NCT04210791","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.9954326674},{"ID":"7091_15_NCT04730765","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible\n\nThe patient is eligible for the clinical trial because they meet the inclusion criteria of having a history of CAD and being diagnosed with pancreatic adenocarcinoma, and they do not meet any of the exclusion criteria listed.","PROBA":0.999850027},{"ID":"10176_15_NCT02081625","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nYes, the patient is eligible for the clinical trial because they have been diagnosed with DMD, and the clinical trial is specifically for patients with DMD. The patient's age and medical history also meet the inclusion criteria, and there are no exclusion criteria that would disqualify the patient from participating in the study.","PROBA":0.9749849226},{"ID":"12547_27_NCT01750515","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.9554264426},{"ID":"8073_17_NCT03984721","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note, the patient has systemic amyloidosis (involvement of lungs, tongue, bladder, heart) and is on hemodialysis for ESRD, which meets the inclusion criteria of the clinical trial. However, the patient has been previously treated with melphalan and prednisone, which are exclusion criteria for the clinical trial. Therefore, the patient is excluded from the clinical trial.\n\nAnswer: B","PROBA":0.9984112348},{"ID":"12485_27_NCT01292161","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9981608316},{"ID":"7792_17_NCT00961467","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20B%20excluded%20C%20not%20relevant%20for%20clinical%20trial","PROBA":0.9914960595},{"ID":"25398_36_NCT03086018","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note and the clinical trial information provided, the patient is eligible for the clinical trial. The patient's complaints of dizziness, nausea, and ringing in the right ear, along with the sensorineural hearing loss in the left ear, align with the inclusion criteria of the clinical trial, which is focused on the evaluation of a new hearing aid. Additionally, the patient's history of hypothyroidism and low vitamin D level, which are being treated with Levothyroxine and Vitamin D pearl, respectively, do not meet any of the exclusion criteria listed in the clinical trial. Therefore, option A (eligible) is the most appropriate response.","PROBA":0.9961603055},{"ID":"7690_17_NCT00153933","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\n based on the patient's note, the patient is eligible for the clinical trial. The patient has multiple myeloma, which is the primary inclusion criterion for the trial. The patient has also received previous treatment with melphalan and prednisone, which is consistent with the trial's inclusion criterion of \"patients with relapsed and relapsed\/refractory multiple myeloma.\" Additionally, the patient's current symptoms of malaise, weakness, and generalized body aching are relevant to the trial's primary outcome measure of assessing the safety and efficacy of the combination of bortezomib and Revlimid in patients with multiple myeloma.\n\nTherefore, the correct answer is (A) eligible.","PROBA":0.9870825809},{"ID":"14123_30_NCT02758977","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9998896718},{"ID":"11608_17_NCT01695369","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B eligible%E2%80%8B\n\nThe patient is eligible for the clinical trial because none of the exclusion criteria are met. The patient's slowly worsening vision in both eyes, loss of the red reflex, and blurry vision are all relevant to the clinical trial's focus on evaluating Comfilcon A and Senofilcon A lenses for the treatment of vision problems. Additionally, the patient's normal pupils and lack of any systemic diseases affecting ocular health make them an eligible candidate.","PROBA":0.9789049549},{"ID":"30849_65_NCT03362762","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.9973460197},{"ID":"5559_12_NCT04731493","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nThe patient is eligible for the clinical trial because she has Marfan's syndrome and known severe mitral valve prolapse with regurgitation, which aligns with the inclusion criteria of the clinical trial. Additionally, the patient is symptomatic and prepared to undergo mitral valve repair\/replacement surgery, which is relevant to the study's objective of evaluating the effect of a therapeutic education program on the quality of life of patients with Marfan syndrome. Therefore, option A (eligible) is the correct response.","PROBA":0.9860479772},{"ID":"30801_65_NCT02782195","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9883796424},{"ID":"6986_15_NCT03858192","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nNo, the patient is not eligible for the clinical trial because they have a history of coronary artery disease and have undergone angioplasty within the past year, which falls under the exclusion criteria of \"ELECTIVE COHORT - Unable to provide written informed consent at time of recruitment and no consultee available - Unable to understand verbal English - Life expectancy less than 30 days.\" Additionally, the patient's history of mitral valve prolapse, atrial fibrillation, and chronic kidney disease may also be considered as exclusion criteria for the study.","PROBA":0.9904637614},{"ID":"7703_17_NCT00256776","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9809747636},{"ID":"19031_27_NCT04148222","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nThe patient is eligible for the clinical trial because they have been diagnosed with Lyme disease, which is the focus of the study, and they do not have any of the exclusion criteria listed (history of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy, postoperative stoma, ostomy, or ileoanal pouch, participation in any experimental drug protocol within the past 12 weeks, treatment with total parenteral nutrition, any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial, or inability to adequately communicate with the investigator or their respective designee and\/or comply with the requirements of the entire study).","PROBA":0.9987979356},{"ID":"7701_17_NCT00240162","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9994012862},{"ID":"25463_36_NCT03600324","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nNo, the patient is excluded from the clinical trial because she has a history of hypothyroidism, which is one of the exclusion criteria.","PROBA":0.975954829},{"ID":"14162_30_NCT03296878","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nNo, the patient is not eligible for the clinical trial because she is not a mother and does not have children living in her household. The exclusion criteria state that only mothers with children living in their household are eligible for the study.","PROBA":0.9988189839},{"ID":"6964_15_NCT03578445","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9318447784},{"ID":"10316_15_NCT03433807","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B%20excluded%20C%20not%20relevant%20for%20clinical%20trial","PROBA":0.9998788225},{"ID":"16862_36_NCT00105066","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient note, the patient is eligible for the clinical trial. The patient meets all the inclusion criteria, which are:\n\n* Age: 32 years old\n* BMI: 41.54, which is within the obese range\n* No prior pregnancies\n* No history of diabetes treated with medication\n* No clinical congestive heart failure\n* No anemia with hematocrit <32%\n* No asthma or COPD requiring daily medication or use of home oxygen therapy\n* No recent, unexplained weight loss of >10% of body weight in the past 6 months\n* No known allergy or hypersensitivity to Metformin\n* No history of hepatitis or cirrhosis\n* No history of kidney disease (defined as serum creatinine >1.4 mg\/dL in men, >1.3 mg\/dL in women)\n\nThe patient does not meet any of the exclusion criteria, which are:\n\n* Diabetes treated with medication\n* Blood pressure >160\/100 mmHg\n* Clinical congestive heart failure\n* Anemia with hematocrit <32%\n* Asthma or COPD requiring daily medication or use of home oxygen therapy\n* Major surgery planned within the next six months\n* A recent, unexplained weight loss of >10% of body weight in the past 6 months\n* A known allergy or hypersensitivity to Metformin\n* History of hepatitis or cirrhosis\n* History of kidney disease (defined as serum creatinine >1.4 mg\/dL in men, >1.3 mg\/dL in women)\n* Pregnancy or the absence of an effective method of contraception\n* Illicit drug or alcohol abuse\n* Cancer requiring treatment currently or recently completed treatment in the last 2 months\n\nTherefore, the patient is eligible for the clinical trial.","PROBA":0.9973640503},{"ID":"27576_40_NCT00970658","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.9952468127},{"ID":"10221_15_NCT02398786","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B%3A%20excluded%20-%20not%20diagnosed%20with%20DM%2C%20unaffected%20family%20members)%20\n\nNo, the patient is not eligible for the clinical trial because they have been diagnosed with DMD, which meets the inclusion criteria. However, the patient's diagnosis does not meet the exclusion criteria of not being diagnosed with DM. Therefore, the patient is eligible for the clinical trial. The correct answer is A: eligible.","PROBA":0.993921921},{"ID":"12509_27_NCT01498068","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.999330318},{"ID":"21420_30_NCT04397484","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B:%20excluded%20-%20prior%20surgery%20in%20the%20popliteal%20fossa%20is%20an%20exclusion%20criterion%20and%20the%20patient%20has%20a%20history%20of%20osteoarthritis%20surgery.","PROBA":0.9923997864},{"ID":"12359_27_NCT00164073","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.9730353713},{"ID":"7078_15_NCT04604730","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20B%20excluded%20C%20not%20relevant%20for%20clinical%20trial).","PROBA":0.9798086152},{"ID":"17158_36_NCT02556749","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.8350099206},{"ID":"25316_36_NCT02467244","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nNo, the patient is excluded from the clinical trial because she is already on levothyroxine therapy, which is one of the exclusion criteria. \n\n$}}%E2%80%8B%20excluded%20\n\nNot relevant for clinical trial. The patient's note does not mention any thyroiditis, and she is not pregnant or lactating, but she is already on levothyroxine therapy, which makes her ineligible for the study. \n\n$}}%E2%80%8B%20not%20relevant%20\n\nCorrect! The patient is excluded from the clinical trial because she is already on levothyroxine therapy, which is one of the exclusion criteria. Good job! Here's the next one.","PROBA":0.996665372},{"ID":"11768_17_NCT02793232","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB","PROBA":0.9302708626},{"ID":"14125_30_NCT02789163","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient is eligible for the clinical trial. The patient is a woman over the age of 18, and the patient has a diagnosis of Hashimoto's thyroiditis, which is not an exclusion criterion. Additionally, the patient has undergone a diagnostic ultrasound examination, which aligns with the clinical trial's inclusion criteria. Therefore, option A is the correct response.","PROBA":0.9935995219},{"ID":"17322_36_NCT03802734","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9991982728},{"ID":"5533_12_NCT04382612","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB. Excluded","PROBA":0.9998981804},{"ID":"10050_15_NCT00830583","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nBased on the patient note, the patient is eligible for the clinical trial because there is no mention of a confirmed and documented diagnosis of an etiologic muscular disease determined by histological analysis, and the patient does not have a familial background known with a X-link or a dominant transmission. Additionally, the patient has not had confirmation of a Pompe disease by biochemical analysis and\/or by molecular biology, and there is no mention of GAA enzymatic activity having been performed. Therefore, the patient meets the inclusion criteria and is eligible for the clinical trial. The correct answer is (A) eligible.","PROBA":0.9918868674},{"ID":"5530_12_NCT04343313","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9693308845},{"ID":"10317_15_NCT03439670","TOPIC_YEAR":2022,"RESPONSE":"# A","PROBA":0.7775565777},{"ID":"30427_65_NCT00283218","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20eligible%20\n\nNo, the patient is excluded from the clinical trial because they have a history of cardiomyopathy, which is listed as an exclusion criterion.","PROBA":0.9872491243},{"ID":"25356_36_NCT02733549","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB","PROBA":0.9074802518},{"ID":"21413_30_NCT04381624","TOPIC_YEAR":2022,"RESPONSE":"$}}%E2%80%8B%20B%20excluded%20C%20not%20relevant%20for%20clinical%20trial","PROBA":0.9832534885},{"ID":"12714_27_NCT03241823","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB","PROBA":0.8844968557},{"ID":"6561_15_NCT00068575","TOPIC_YEAR":2021,"RESPONSE":"$}}%A%] eligible","PROBA":0.9104177505},{"ID":"33403_71_NCT00297154","TOPIC_YEAR":2021,"RESPONSE":"# A: eligible","PROBA":0.9904945344},{"ID":"21305_30_NCT03736109","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB","PROBA":0.8767256618}]
